Cargando…
Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy
BACKGROUND: We describe the risk indicators for oral mucositis (OM) in paediatric oncology patients hospitalised in the Institut Gustave Roussy (Villejuif-Paris) and treated with alkylant chemotherapy with autologous peripheral blood progenitor cells. METHODS: The sample was selected using PIGAS sof...
Autores principales: | Fadda, Giulia, Campus, Guglielmo, Lugliè, PierFranca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1629008/ https://www.ncbi.nlm.nih.gov/pubmed/17049085 http://dx.doi.org/10.1186/1472-6831-6-13 |
Ejemplares similares
-
Oral Characteristics of Trisomy 8 and Monosomy 18: A Case Report
por: Spano, Giovanni, et al.
Publicado: (2011) -
Chemotherapy in Pediatric Oncology Patients and the Occurrence of Oral Mucositis
por: Ribeiro, Isabella LA, et al.
Publicado: (2019) -
Prevention and treatment of oral mucositis
in patients receiving chemotherapy
por: Alvariño-Martín, Carlos, et al.
Publicado: (2014) -
Use of Honey in the Management of Chemotherapy-Associated Oral Mucositis in Paediatric Patients
por: Zhang, Luyang, et al.
Publicado: (2022) -
Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy
por: Yeh, C-H, et al.
Publicado: (2008)